Could cause temporary or reversible harm; serious harm is unlikely.
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
| Brand name | ONDANSETRON |
| Generic name | ONDANSETRON |
| Active ingredient(s) | ONDANSETRON HYDROCHLORIDE |
| Distributed by / for | Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India |
| NDC | 68462-157-13 |
| Full product label | Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13 |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
| Distribution | Nationwide within the United States |
| Quantity | 96,948 packs |
| Recall initiated | 2025-12-30 |
| Report date | 2026-01-07 |
| Recall completed | — |
| Recall number | D-0246-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Elmwood Park NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗